Gentex Corp (GNTX) stock
Close on Nov 17, 2026Market cap $3.96BP/E 9.9Yield 2.55%
Earnings
Gentex's quarterly results as reported in its earnings releases, with the company's own outlook. Hover a number to see the sentence it came from.
Quarterly results
Revenue and earnings per share from each of Gentex's earnings releases, newest first
| Quarter | Reported | Revenue | YoY | EPS | Adj. EPS | Source |
|---|---|---|---|---|---|---|
| Q4 FY2026ended Dec 31, 2026 | Jan 29, 2027Expected | – | – | – | – | – |
| Q3 FY2026ended Sep 30, 2026 | Oct 23, 2026before the open | $647.70M | -1.1% | $0.43 | $0.47 | Release |
| Q2 FY2026ended Jun 30, 2026 | Jul 24, 2026before the open | $651.30M | -1.0% | $0.54 | $0.58 | Release |
| Q1 FY2026ended Mar 31, 2026 | Apr 24, 2026before the open | $675.40M | +17.1% | $0.46 | $0.48 | Release |
| Q4 FY2025ended Dec 31, 2025 | Jan 30, 2026before the open | $644.40M | +19.0% | $0.43 | – | Release |
| Q3 FY2025ended Sep 30, 2025 | Oct 24, 2025before the open | $655.20M | +7.7% | $0.46 | – | Release |
| Q2 FY2025ended Jun 30, 2025 | Jul 25, 2025before the open | $657.90M | +14.8% | $0.43 | $0.47 | Release |
| Q1 FY2025ended Mar 31, 2025 | Apr 25, 2025before the open | $576.80M | -2.3% | $0.42 | – | Release |
| Q4 FY2024ended Dec 31, 2024 | Jan 31, 2025before the open | $541.60M | -8.1% | $0.39 | – | Release |
| Q3 FY2024ended Sep 30, 2024 | Oct 25, 2024before the open | $608.50M | +5.7% | $0.53 | – | Release |
| Q2 FY2024ended Jun 30, 2024 | Jul 26, 2024before the open | $572.90M | -1.8% | $0.37 | – | Release |
| Q1 FY2024ended Mar 31, 2024 | Apr 26, 2024before the open | $590.20M | +7.2% | $0.47 | – | Release |
| Q4 FY2023ended Dec 31, 2023 | Jan 26, 2024before the open | $589.10M | +19.3% | $0.50 | – | Release |
| Q3 FY2023ended Sep 30, 2023 | Oct 27, 2023before the open | $575.80M | +16.7% | $0.45 | – | Release |
| Q2 FY2023ended Jun 30, 2023 | Jul 28, 2023before the open | $583.50M | – | $0.47 | – | Release |
| Q1 FY2023ended Mar 31, 2023 | Apr 28, 2023before the open | $550.80M | +17.6% | $0.42 | – | Release |
| Q4 FY2022ended Dec 31, 2022 | Jan 27, 2023before the open | $493.60M | +17.6% | $0.37 | – | Release |
| Q3 FY2022ended Sep 30, 2022 | Oct 28, 2022before the open | $493.60M | +23.5% | $0.31 | – | Release |
| Q1 FY2022ended Mar 31, 2022 | Apr 22, 2022before the open | $468.30M | – | $0.37 | – | Release |
| Q4 FY2021ended Dec 31, 2021 | Jan 28, 2022before the open | $419.80M | – | $0.35 | – | Release |
| Q3 FY2021ended Sep 30, 2021 | Oct 22, 2021before the open | $399.60M | – | $0.32 | – | Release |
| Q2 FY2021ended Jun 30, 2021 | Jul 23, 2021before the open | – | – | – | – | Filing |
| Q1 FY2021ended Mar 31, 2021 | Apr 23, 2021before the open | – | – | – | – | Filing |
| Q4 FY2020ended Dec 31, 2020 | Jan 29, 2021before the open | – | – | – | – | Filing |
| Q3 FY2020ended Sep 30, 2020 | Oct 23, 2020before the open | – | – | – | – | Filing |
| Q2 FY2020ended Jun 30, 2020 | Jul 24, 2020before the open | – | – | – | – | Filing |
Figures as first announced; later restatements appear under Financials. Expected dates are estimated from the company's past reporting pattern.
Current guidance
Gentex's latest outlook for periods it has not reported yet, compared with what it said before
| Metric | Period | Guidance | Before | Change | Given |
|---|---|---|---|---|---|
| Consolidated Revenue | FY2026 | $2.65B | $2.55B – $2.65B | Raised | Oct 23, 2026 |
| Consolidated Revenue | FY2026 | $2.65B – $2.75B | $2.65B – $2.75B | Reaffirmed | Jul 24, 2026 |
| Gross Margin | FY2026 | 34% – 34.5% | – | New | Oct 23, 2026 |
| Gross Margin | FY2026 | 34.5% – 35.5% | 34% – 35% | Raised | Jul 24, 2026 |
| Capital Expenditures | FY2026 | $100.00M – $115.00M | – | New | Oct 23, 2026 |
| Capital Expenditures | FY2026 | $115.00M – $125.00M | $125.00M – $140.00M | Lowered | Jul 24, 2026 |
| Depreciation & Amortization | FY2026 | $100.00M – $105.00M | – | New | Oct 23, 2026 |
| Depreciation & Amortization | FY2026 | $100.00M – $110.00M | $100.00M – $110.00M | Reaffirmed | Jul 24, 2026 |
| Estimated Annual Tax Rate | FY2026 | 16% – 18% | – | New | Jan 30, 2026 |
| Operating Expenses (E,R&D and S,G&A) | FY2026 | $410.00M – $420.00M | – | New | Jan 30, 2026 |
| Operating Expenses (excluding severance and impairments )non-GAAP | FY2026 | $405.00M – $415.00M | $410.00M – $420.00M | Lowered | Jul 24, 2026 |
| Operating Expenses (excluding severance and impairments)non-GAAP | FY2026 | $395.00M – $410.00M | – | New | Oct 23, 2026 |
| Tax Rate | FY2026 | 16% – 16.5% | – | New | Oct 23, 2026 |
| Tax Rate | FY2026 | 16% – 17% | 16% – 18% | Lowered | Jul 24, 2026 |
| calendar-year 2027 revenue | FY2027 | $2.80B – $2.90B | $2.80B – $2.90B | Reaffirmed | Jul 24, 2026 |
| revenue outlook | FY2027 | $2.80B – $2.90B | – | New | Oct 23, 2026 |
Guidance vs results
The last range Gentex gave before each report, against the figure it then reported. Full years add up the four quarters.
| Period | Metric | Guidance | Actual | Result |
|---|---|---|---|---|
| FY2025 | Revenue | $2.50B – $2.60B | $2.53BΣ4Q | Within range |
Guidance history
Every forecast Gentex put in an earnings release, newest first
| Given | Metric | Period | Guidance | Change |
|---|---|---|---|---|
| Oct 23, 2026 | Capital Expenditures | FY2026 | $100.00M – $115.00M | New |
| Oct 23, 2026 | Gross Margin | FY2026 | 34% – 34.5% | New |
| Oct 23, 2026 | Tax Rate | FY2026 | 16% – 16.5% | New |
| Oct 23, 2026 | Depreciation & Amortization | FY2026 | $100.00M – $105.00M | New |
| Oct 23, 2026 | Operating Expenses (excluding severance and impairments) | FY2026 | $395.00M – $410.00M | New |
| Oct 23, 2026 | Consolidated Revenue | FY2026 | $2.65B | Raised |
| Oct 23, 2026 | revenue outlook | FY2027 | $2.80B – $2.90B | New |
| Jul 24, 2026 | Capital Expenditures | FY2026 | $115.00M – $125.00M | Lowered |
| Jul 24, 2026 | Gross Margin | FY2026 | 34.5% – 35.5% | Raised |
| Jul 24, 2026 | Tax Rate | FY2026 | 16% – 17% | Lowered |
| Jul 24, 2026 | Depreciation & Amortization | FY2026 | $100.00M – $110.00M | Reaffirmed |
| Jul 24, 2026 | Operating Expenses (excluding severance and impairments ) | FY2026 | $405.00M – $415.00M | Lowered |
| Jul 24, 2026 | Consolidated Revenue | FY2026 | $2.65B – $2.75B | Reaffirmed |
| Jul 24, 2026 | calendar-year 2027 revenue | FY2027 | $2.80B – $2.90B | Reaffirmed |
| Apr 24, 2026 | Capital Expenditures | FY2026 | $125.00M – $140.00M | Reaffirmed |
| Apr 24, 2026 | Gross Margin | FY2026 | 34% – 35% | Reaffirmed |
| Apr 24, 2026 | Tax Rate | FY2026 | 16% – 18% | Reaffirmed |
| Apr 24, 2026 | Depreciation & Amortization | FY2026 | $100.00M – $110.00M | Reaffirmed |
| Apr 24, 2026 | Operating Expenses (excluding severance and impairments ) | FY2026 | $410.00M – $420.00M | New |
| Apr 24, 2026 | Consolidated Revenue | FY2026 | $2.65B – $2.75B | Raised |
| Apr 24, 2026 | revenue | FY2027 | $2.80B – $2.90B | Raised |
| Jan 30, 2026 | Capital Expenditures | FY2026 | $125.00M – $140.00M | New |
| Jan 30, 2026 | Gross Margin | FY2026 | 34% – 35% | New |
| Jan 30, 2026 | Estimated Annual Tax Rate | FY2026 | 16% – 18% | New |
| Jan 30, 2026 | Operating Expenses (E,R&D and S,G&A) | FY2026 | $410.00M – $420.00M | New |
| Jan 30, 2026 | Depreciation & Amortization | FY2026 | $100.00M – $110.00M | Lowered |
| Jan 30, 2026 | Revenue | FY2026 | $2.60B – $2.70B | New |
| Jan 30, 2026 | revenue | FY2027 | $2.75B – $2.85B | New |
| Oct 24, 2025 | Capital Expenditures | FY2025 | $115.00M – $125.00M | New |
| Oct 24, 2025 | Gross Margin | FY2025 | 33.5% – 34% | New |
| Oct 24, 2025 | Gentex (stand-alone) | FY2025 | 34.25% – 34.75% | Raised |
| Oct 24, 2025 | VOXX (stand-alone) | FY2025 | 28% – 29% | Lowered |
| Oct 24, 2025 | Tax Rate | FY2025 | 16% – 16.5% | New |
| Oct 24, 2025 | Operating Expenses (excluding severance ) | FY2025 | $380.00M – $390.00M | New |
| Oct 24, 2025 | Gentex | FY2025 | $305.00M – $310.00M | Lowered |
| Oct 24, 2025 | VOXX | FY2025 | $75.00M – $80.00M | Lowered |
| Oct 24, 2025 | Depreciation & Amortization | FY2025 | $96.00M – $99.00M | Raised |
| Oct 24, 2025 | Gentex | FY2025 | $95.00M – $96.00M | Lowered |
| Oct 24, 2025 | VOXX | FY2025 | $1.00M – $3.00M | Lowered |
| Oct 24, 2025 | Consolidated Revenue | FY2025 | $2.50B – $2.60B | New |
| Oct 24, 2025 | Gentex China market | FY2025 | $135.00M – $145.00M | Lowered |
| Oct 24, 2025 | VOXX Revenue estimate | FY2025 | $250.00M – $275.00M | Raised |
| Oct 24, 2025 | Gentex primary markets | FY2025 | $2.14B – $2.15B | Lowered |
| Jul 25, 2025 | Capital Expenditures | FY2025 | $100.00M – $125.00M | Lowered |
| Jul 25, 2025 | Gross Margin | FY2025 | 33% – 34% | Lowered |
| Jul 25, 2025 | Gentex (stand-alone) | FY2025 | 34% – 34.5% | Raised |
| Jul 25, 2025 | VOXX (stand-alone) | FY2025 | 27% – 29% | Lowered |
| Jul 25, 2025 | Tax Rate | FY2025 | 16% – 17% | Raised |
| Jul 25, 2025 | Gentex | FY2025 | $300.00M – $310.00M | Raised |
| Jul 25, 2025 | VOXX | FY2025 | $70.00M – $80.00M | Lowered |
| Jul 25, 2025 | Depreciation & Amortization | FY2025 | $91.00M – $98.00M | Raised |
| Jul 25, 2025 | Gentex | FY2025 | $90.00M – $95.00M | Lowered |
| Jul 25, 2025 | VOXX | FY2025 | $1.00M – $3.00M | Lowered |
| Jul 25, 2025 | Operating Expenses (New consolidated guidance, excluding severance ) | FY2025 | $370.00M – $390.00M | New |
| Jul 25, 2025 | Consolidated Revenue | FY2025 | $2.44B – $2.61B | Raised |
| Jul 25, 2025 | Gentex primary markets | FY2025 | $2.10B – $2.20B | Lowered |
| Jul 25, 2025 | Gentex China market | FY2025 | $100.00M – $125.00M | Lowered |
| Jul 25, 2025 | VOXX Revenue estimate | FY2025 | $240.00M – $280.00M | Raised |
| Apr 25, 2025 | expected revenue contribution | FY2025 | $240.00M – $280.00M | Lowered |
| Jan 31, 2025 | Capital Expenditures | FY2025 | $125.00M – $150.00M | New |
| Jan 31, 2025 | Gross Margin | FY2025 | 33.5% – 34.5% | New |
| Jan 31, 2025 | Estimated Annual Tax Rate | FY2025 | 15% – 17% | New |
| Jan 31, 2025 | Operating Expenses (E,R&D and S,G&A) | FY2025 | $310.00M – $320.00M | New |
| Jan 31, 2025 | Depreciation & Amortization | FY2025 | $85.00M – $90.00M | Lowered |
| Jan 31, 2025 | Revenue | FY2025 | $2.40B – $2.45B | Lowered |
| Jan 31, 2025 | revenue | FY2026 | $2.55B – $2.65B | New |
| Oct 25, 2024 | Capital Expenditures | FY2024 | $150.00M – $175.00M | Lowered |
| Oct 25, 2024 | Gross Margin | FY2024 | 33.5% – 34% | Lowered |
| Oct 25, 2024 | Tax Rate | FY2024 | 15% – 15.5% | Lowered |
| Oct 25, 2024 | Operating Expenses | FY2024 | $295.00M – $305.00M | Raised |
| Oct 25, 2024 | Depreciation & Amortization | FY2024 | $90.00M – $95.00M | Lowered |
| Oct 25, 2024 | Revenue | FY2024 | $2.35B – $2.40B | Lowered |
| Oct 25, 2024 | revenue | FY2025 | $2.45B – $2.55B | Lowered |
| Jul 26, 2024 | Capital Expenditures | FY2024 | $175.00M – $200.00M | Lowered |
| Jul 26, 2024 | Gross Margin | FY2024 | 34% – 34.5% | Lowered |
| Jul 26, 2024 | Tax Rate | FY2024 | 15% – 16% | Lowered |
| Jul 26, 2024 | Operating Expenses | FY2024 | $295.00M – $305.00M | Raised |
| Jul 26, 2024 | Depreciation & Amortization | FY2024 | $95.00M – $100.00M | Lowered |
| Jul 26, 2024 | Revenue | FY2024 | $2.40B – $2.50B | Lowered |
| Jul 26, 2024 | revenue estimates | FY2025 | $2.60B – $2.70B | Lowered |
| Apr 26, 2024 | revenue | FY2025 | $2.65B – $2.75B | Reaffirmed |
| Jan 26, 2024 | Capital Expenditures | FY2024 | $225.00M – $250.00M | New |
| Jan 26, 2024 | Gross Margin | FY2024 | 34% – 35% | New |
| Jan 26, 2024 | Estimated Annual Tax Rate | FY2024 | 16% – 18% | New |
| Jan 26, 2024 | Operating Expenses (E,R&D and S,G&A) | FY2024 | $295.00M – $305.00M | New |
| Jan 26, 2024 | Depreciation & Amortization | FY2024 | $95.00M – $105.00M | Lowered |
| Jan 26, 2024 | Revenue | FY2024 | $2.45B – $2.55B | Reaffirmed |
| Jan 26, 2024 | revenue | FY2025 | $2.65B – $2.75B | New |
| Oct 27, 2023 | Capital Expenditures | FY2023 | $200.00M – $215.00M | Lowered |
| Oct 27, 2023 | Gross Margin | FY2023 | 32.5% – 33% | Reaffirmed |
| Oct 27, 2023 | Tax Rate | FY2023 | 15% – 15.5% | Lowered |
| Oct 27, 2023 | Operating Expenses | FY2023 | $260.00M – $270.00M | Raised |
| Oct 27, 2023 | Depreciation & Amortization | FY2023 | $95.00M – $100.00M | Lowered |
| Oct 27, 2023 | Revenue | FY2023 | $2.20B – $2.30B | Reaffirmed |
| Oct 27, 2023 | revenue | FY2024 | $2.45B – $2.55B | Reaffirmed |
| Jul 28, 2023 | Capital Expenditures | FY2023 | $200.00M – $225.00M | Reaffirmed |
| Jul 28, 2023 | Gross Margin | FY2023 | 32.5% – 33% | Raised |
| Jul 28, 2023 | Tax Rate | FY2023 | 15% – 16% | Lowered |
| Jul 28, 2023 | Operating Expenses | FY2023 | $260.00M – $270.00M | Raised |
| Jul 28, 2023 | Depreciation & Amortization | FY2023 | $100.00M – $110.00M | Lowered |
| Jul 28, 2023 | Revenue | FY2023 | $2.20B – $2.30B | Raised |
| Jul 28, 2023 | revenue | FY2024 | $2.45B – $2.55B | New |
| Apr 28, 2023 | Capital Expenditures | FY2023 | $200.00M – $225.00M | Reaffirmed |
| Apr 28, 2023 | Gross Margin | FY2023 | 32% – 33% | Reaffirmed |
| Apr 28, 2023 | Tax Rate | FY2023 | 15% – 17% | Reaffirmed |
| Apr 28, 2023 | Operating Expenses | FY2023 | $260.00M – $270.00M | Raised |
| Apr 28, 2023 | Depreciation & Amortization | FY2023 | $100.00M – $110.00M | Lowered |
| Apr 28, 2023 | Revenue | FY2023 | $2.20B | Reaffirmed |
| Apr 28, 2023 | revenue growth | FY2024 | +10% | Reaffirmed |
| Jan 27, 2023 | Capital Expenditures | FY2023 | $200.00M – $225.00M | New |
| Jan 27, 2023 | Gross Margin | FY2023 | 32% – 33% | New |
| Jan 27, 2023 | Estimated Annual Tax Rate | FY2023 | 15% – 17% | New |
| Jan 27, 2023 | Operating Expenses (E,R&D and S,G&A) | FY2023 | $260.00M – $270.00M | New |
| Jan 27, 2023 | Depreciation & Amortization | FY2023 | $100.00M – $110.00M | Lowered |
| Jan 27, 2023 | Revenue | FY2023 | $2.20B | New |
| Jan 27, 2023 | revenue growth | FY2024 | +10% | New |
| Oct 28, 2022 | Capital Expenditures | FY2022 | $140.00M – $150.00M | Lowered |
| Oct 28, 2022 | Gross Margin | FY2022 | 32% – 33% | Lowered |
| Oct 28, 2022 | Tax Rate | FY2022 | 14% – 15% | Lowered |
| Oct 28, 2022 | Operating Expenses | FY2022 | $235.00M – $240.00M | Raised |
| Oct 28, 2022 | Depreciation & Amortization | FY2022 | $100.00M – $105.00M | Lowered |
| Oct 28, 2022 | Revenue | FY2022 | $1.90B – $1.95B | Narrowed |
| Oct 28, 2022 | revenue growth | FY2023 | +15% – +20% | Reaffirmed |
| Apr 22, 2022 | Capital Expenditures | FY2022 | $150.00M – $175.00M | Reaffirmed |
| Apr 22, 2022 | Gross Margin | FY2022 | 35% – 36% | Reaffirmed |
| Apr 22, 2022 | Tax Rate | FY2022 | 15% – 17% | Reaffirmed |
| Apr 22, 2022 | Operating Expenses | FY2022 | $230.00M – $240.00M | Raised |
| Apr 22, 2022 | Depreciation & Amortization | FY2022 | $100.00M – $110.00M | Lowered |
| Apr 22, 2022 | Revenue | FY2022 | $1.87B – $2.02B | Reaffirmed |
| Apr 22, 2022 | revenue growth | FY2023 | +15% – +20% | Reaffirmed |
| Jan 28, 2022 | Capital Expenditures | FY2022 | $150.00M – $175.00M | New |
| Jan 28, 2022 | Gross Margin | FY2022 | 35% – 36% | New |
| Jan 28, 2022 | Estimated Annual Tax Rate | FY2022 | 15% – 17% | New |
| Jan 28, 2022 | Operating Expenses (E,R&D and S,G&A) | FY2022 | $230.00M – $240.00M | New |
| Jan 28, 2022 | Depreciation & Amortization | FY2022 | $100.00M – $110.00M | Lowered |
| Jan 28, 2022 | Revenue | FY2022 | $1.87B – $2.02B | New |
| Jan 28, 2022 | revenue growth | FY2023 | +15% – +20% | New |
| Oct 22, 2021 | Capital Expenditures | FY2021 | $50.00M – $60.00M | New |
| Oct 22, 2021 | Gross Margin | FY2021 | 35% – 36% | New |
| Oct 22, 2021 | Tax Rate | FY2021 | 15% – 16% | New |
| Oct 22, 2021 | Operating Expenses | FY2021 | $105.00M – $108.00M | New |
| Oct 22, 2021 | Depreciation & Amortization | FY2021 | $48.00M – $52.00M | Lowered |
| Oct 22, 2021 | net sales | FY2021 | $770.00M – $840.00M | New |
| Oct 22, 2021 | revenue estimates | FY2021 | $1.68B – $1.75B | Raised |
| Oct 22, 2021 | revenue | FY2022 | +15% – +20% | New |
Read from the company's earnings releases; each figure links to its sentence on hover. “Raised” and “Lowered” compare with the previous range for the same metric and period.
Press releases
Releases Gentex filed with the SEC as exhibits to Form 8-K or 6-K
- Results
- Results
- Results
- Results
- Results
- Results
- Results
- Update
- Results
- News
- Results
- Results
- Results
- Results
- Results
See a number that looks wrong?